Mental Health Improved Following First Dose of COVID-19 Vaccine
Adults receiving the vaccine between December 2020 and March 2021 reported decreased mental distress following first dose
Immunization
MPR Weekly Dose Podcast Episode 92
This week we have news on pediatric influenza vaccine guidance; Moderna submit data for their COVID-19 booster dose; There’s new FDA warnings for some JAK inhibitors; Trudhesa nasal spray is approved; And the FDA places a clinical hold on a gene therapy for phenylketonuria.
mRNA COVID-19 Vaccines Immunogenic in Immunosuppressed Patients
Titers of anti-S IgG lower for patients with chronic inflammatory disease receiving glucocorticoids or B-cell depletion therapy
AAP Updates Influenza Vaccination Guidance for Children
Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no medical contraindications.
Interim Data Show No Increase in Serious Outcomes Post-COVID-19 Vaccination
Incidence of ischemic stroke, appendicitis, or acute myocardial infarction not increased one to 21 days after mRNA COVID-19 vaccination
Which Cancer Patients Need a COVID-19 Booster Shot Most?
NCCN guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines
FDA Advisory Panel Set to Meet on COVID-19 Booster Shots
Public session could add clarity or controversy to what some feel has been a confusing decision-making process
Moderna Submits COVID-19 Vaccine Booster Data for FDA Review
A single 50µg dose of mRNA-1273 given as a booster increased neutralizing antibody titer responses above the phase 3 benchmark.
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
CDC: Unvaccinated Should Not Travel This Labor Day Weekend
Agency urges fully vaccinated people to travel with precautions, take infection risk into consideration
